Belorusija - ruščina - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

sorin group italia s.r.l., ИТАЛИЯ -

Združene države Amerike - angleščina - NLM (National Library of Medicine)

pvs nolwood chemicals, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic, hand sanitizer hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available. - in children less than 2 months of age - on open skin wounds stop use and ask a doctor if irritation or rash occurs. these may be signs of a serious condition.

Belorusija - ruščina - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

corcym s.r.l., ИТАЛИЯ -

Belorusija - ruščina - Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)

corcym s.r.l., ИТАЛИЯ -

Evropska unija - litovščina - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - imipenem monohidratas, cilastatin natrio, relebactam monohidratas - gram-neigiamų bakterijų infekcijos - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 ir 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4 ir 5. reikėtų atsižvelgti į oficialius nurodymus, kaip tinkamai naudoti antibakterinių veiksnių.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aurobindo pharma limited - gabapentin - kapsula, trda - gabapentin 300 mg / 1 kapsula - gabapentin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aurobindo pharma limited - gabapentin - kapsula, trda - gabapentin 400 mg / 1 kapsula - gabapentin

Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - erlotinibhydrochlorid - filmovertrukne tabletter - 100 mg

Danska - danščina - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - erlotinibhydrochlorid - filmovertrukne tabletter - 150 mg

Združene države Amerike - angleščina - NLM (National Library of Medicine)

twi pharmaceuticals, inc. - dexlansoprazole (unii: uye4t5i70x) (dexlansoprazole - unii:uye4t5i70x) - dexlansoprazole delayed-release capsules are indicated in patients 12 years of age and older for healing of all grades of erosive esophagitis (ee) for up to eight weeks. dexlansoprazole delayed-release capsules are indicated in patients 12 years of age and older to maintain healing of ee and relief of heartburn for up to six months in adults and 16 weeks in patients 12 to 17 years of age. dexlansoprazole delayed-release capsules are indicated in patients 12 years of age and older for the treatment of heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (gerd) for four weeks. - dexlansoprazole delayed-release capsules are contraindicated in patients with known hypersensitivity to any component of the formulation [see description (11)] . hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis and urticaria [see warnings and precautions (5.2), adverse reactions (6)] . - ppis, including dexlansoprazole delaye